Engineers and oncologists teamed to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.

A new understanding of intracellular pathways activated as T cells start to mount an immune response offers clues against graft-versus-host disease, a serious complication of bone marrow transplantation.

The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.

Throughout the pandemic, researchers have continued to push the boundaries of cancer prevention, diagnosis and treatment.

An endocrinologist specializing in thyroid cancer and creator of the Hemoglobin A1c test for diabetes reflects on his career, offering advice for aspiring researchers.

The U-M-led development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials.